These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22469507)

  • 1. SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms' tumor.
    Zin R; Pham K; Ashleigh M; Ravine D; Waring P; Charles A
    Cancer Genet; 2012 Mar; 205(3):80-93. PubMed ID: 22469507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors.
    Dougherty MJ; Tooke LS; Sullivan LM; Hakonarson H; Wainwright LM; Biegel JA
    Cancer Genet; 2012; 205(1-2):42-54. PubMed ID: 22429597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.
    Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP
    Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
    Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
    Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 1q44 deletion, paternal UPD of chromosome 2 and a deletion due to a complex translocation detected in children with abnormal phenotypes using new SNP array technology.
    Talseth-Palmer BA; Bowden NA; Meldrum C; Nicholl J; Thompson E; Friend K; Liebelt J; Bratkovic D; Haan E; Yu S; Scott RJ
    Cytogenet Genome Res; 2009; 124(1):94-101. PubMed ID: 19372674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent occurrence of uniparental disomy in colorectal cancer.
    Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
    Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
    Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA
    Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics.
    Krupp W; Holland H; Koschny R; Bauer M; Schober R; Kirsten H; Livrea M; Meixensberger J; Ahnert P
    Cancer Genet Cytogenet; 2008 Jul; 184(2):87-93. PubMed ID: 18617056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia.
    Huh J; Jung CW; Kim JW; Kim HJ; Kim SH; Shin MG; Kim YK; Kim HJ; Suh JS; Moon JH; Sohn SK; Nam GH; Lee JE; Kim DH
    Ann Hematol; 2011 Nov; 90(11):1255-64. PubMed ID: 21384125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors.
    Kaneko Y; Homma C; Maseki N; Sakurai M; Hata J
    Cancer Res; 1991 Nov; 51(21):5937-42. PubMed ID: 1657374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-genome single nucleotide polymorphism array analysis is complementary to classical cytogenetic analysis in the evaluation of lymphoid proliferations.
    Gibson SE; Luo J; Sathanoori M; Liao J; Surti U; Swerdlow SH
    Am J Clin Pathol; 2014 Feb; 141(2):247-55. PubMed ID: 24436273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
    Maciejewski JP; Tiu RV; O'Keefe C
    Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
    da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
    J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
    Wang L; Fidler C; Nadig N; Giagounidis A; Della Porta MG; Malcovati L; Killick S; Gattermann N; Aul C; Boultwood J; Wainscoat JS
    Haematologica; 2008 Jul; 93(7):994-1000. PubMed ID: 18508791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of chromosomal aberrations in renal tumors: a comparative study of conventional cytogenetics and virtual karyotyping with single-nucleotide polymorphism microarrays.
    Monzon FA; Alvarez K; Gatalica Z; Bridge JA; Nelson M; Kim HJ; Hagenkord JM
    Arch Pathol Lab Med; 2009 Dec; 133(12):1917-22. PubMed ID: 19961245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome.
    Grundy PE; Telzerow PE; Breslow N; Moksness J; Huff V; Paterson MC
    Cancer Res; 1994 May; 54(9):2331-3. PubMed ID: 8162576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for submicroscopic chromosomal rearrangements in Wilms tumor using whole-genome microarrays.
    Rassekh SR; Chan S; Harvard C; Dix D; Qiao Y; Rajcan-Separovic E
    Cancer Genet Cytogenet; 2008 Apr; 182(2):84-94. PubMed ID: 18406869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple meningioma with different grades of malignancy: case report with genetic analysis applying single-nucleotide polymorphism array and classical cytogenetics.
    Mocker K; Holland H; Ahnert P; Schober R; Bauer M; Kirsten H; Koschny R; Meixensberger J; Krupp W
    Pathol Res Pract; 2011 Jan; 207(1):67-72. PubMed ID: 20926204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.